Short Position for SPL shares at 19-11-2018, page-22

Whilst I agree that AB upramps on the odd occasion, at least he backs up his upramping with factual evidence.

I am optimistic but also realistic in my expectations based on previous performances of SPL. It really does seem like all signs are pointing to AZD00466 going into clinic in 2019. If it does not, then maybe the $1 mark is possible. Once it does go into clinic it will open up starpharma to a whole new shareholder base and I would hope that the SP will rise as a result.

@DanHicks can you provide any justification why you are downramping? Back up your predictions with some factual evidence..... then other posters might actually listen to you.